Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
DNA Ginkgo Bioworks Holdings, Inc.
With the start of the new year, Preserving Home is building on a new chapter… Windjam Companies is a privately held, Cary-based parent company specializing in luxury real estate… Join Triangle ...
Dec 23, 2025, 8:18 am EST Sports Business © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback